21SEP

Exeter spinout raises £3m for epilepsy

2 min read

16:52UTC

Neuronostics, an Exeter University spinout, raised £3m for BioEP, an EEG-based epilepsy biomarker, co-led by Empirical Ventures and The FSE Group with an Innovate UK grant.

← Back to Nscale takes $103.4bn of contracts to NYSE Jump to analysis ↓

TechnologyDeveloping

Key takeaway

Neuronostics paired a specialist fund with an Innovate UK grant to raise in the shrinking spinout tier.

Neuronostics, a University of Exeter spinout, raised £3m for BioEP, a digital biomarker that reads routine EEG (electroencephalogram, a recording of the brain's electrical activity) to help diagnose epilepsy without waiting for a seizure ¹. Empirical Ventures, a UK health-specialist investor, and The FSE Group, a regional fund manager, co-led, with the British Business Bank, Ascension, QantX, New Wave and Bristol angels, blended with a £400k Innovate UK Investor Partnerships grant, a government co-investment programme.

The round sits in exactly the sub-£5m spinout tier the national tracker shows contracting sharply in 2025 . A specialist fund co-led it and Innovate UK grant money topped it up.

The Innovate UK grant matches private capital rather than replacing it, so £400k de-risks the private cheques around it, a different instrument from the VCT tax relief April's change cut. Blended public-grant-plus-equity rounds like this are how the thin end of the spinout pipeline is being held together one deal at a time.

Deep Analysis

In plain English

Neuronostics grew out of research at the University of Exeter. It has built BioEP, a tool that reads routine brain-wave recordings, known as EEGs, to help doctors diagnose epilepsy faster and without more invasive tests. The company raised £3m from two co-lead investors, plus a £400k top-up grant from Innovate UK, a government body that part-funds promising new British technology.

Source Landscape

This story draws on neutral-leaning sources

At £3m plus a £400k grant, Neuronostics' total funding of £3.4m is modest for a diagnostics platform that still needs clinical validation before wider NHS adoption, leaving little room for delay.

The grant covers roughly one-eighth of the round, which shows how thin Innovate UK's remaining early-stage funding pool has become relative to the private capital now doing most of the work that public grants used to carry alone.

Consensus view: The Wellcome Trust's health-innovation funding team sees blended structures like Neuronostics' £3m round, topped up with a £400k Innovate UK grant, becoming the default model for early health-tech spinouts as the retail angel base that used to fund them keeps shrinking .

Counter-view: Midlands Mindforge, the eight-university fund that wrote its first cheques in June , argues blended grant-equity financing is a stopgap: pooling several universities' capital directly into one larger regional fund still leaves an individual spinout better capitalised than a small private round patched together with a government top-up.

Key tension: Whether blended grant-and-equity financing is a durable long-term model for health-tech spinouts, or a patchwork response to a shrinking angel base that regional multi-university funds are better placed to fix.

Sources:UKTN

Mentions:Neuronostics →Radical Ventures →The FSE Group →British Business Bank →Innovate UK →Midlands Mindforge →Bristol →Fudan University →

First Reported In

Update #10 · AI takes record 44% as UK equity shrinks

UKTN· 4 Jul 2026

Read original →

Causes and effects

This Event

Exeter spinout raises £3m for epilepsy

A blended specialist-fund and government-grant round shows the contracting spinout tier is thinner, not closed.

Led to

Five UK deep-tech firms raise £41.5m in a week

Neuronostics' £3m epilepsy-biomarker round is part of the same thin, cross-sector seed tier this week's cluster extends.

Occurred 8 Jul 2026

Read story →

Different Perspectives

Nscale and Open Cosmos

Nscale chose the New York Stock Exchange for its listing on 18 September, putting Britain's largest AI infrastructure bet to American public investors rather than British ones. Open Cosmos took the opposite route four days earlier, raising nine figures from an all-domestic syndicate on five years of profit, evidence that staying is possible when the balance sheet allows it.

Dame Chi Onwurah and the Science, Innovation and Technology Committee

Committee chair Dame Chi Onwurah wrote to government on 7 September asking how Matt Clifford's conflict at ARIA arose and what safeguards protect its governance, and expects a detailed response. Her question has not yet been put to the Sovereign AI Unit, whose own chair sits at a venture capital firm while overseeing state AI equity.

The Entrepreneurs Network

The Entrepreneurs Network's founder survey found 65% say Britain is easy to start a business in but only 14% say it is easy to scale one, with 82% negative on tax and 74% finding investment hard to access. On this reading the constraint is regulation and tax, not the capital-vehicle design the state keeps adjusting.

New Economics Foundation

The New Economics Foundation argues fiscal accounting rules, not political will, cap what Britain's state capital vehicles can do. Matching the KfW and Bpifrance benchmark of 1% of GDP would need the National Wealth Fund to deploy roughly GBP21bn a year by 2028-29, about four times its current capacity.

Competition and Markets Authority

The CMA's 8 September report on public procurement asked whether Britain's roughly GBP400bn state-spending system is built to grow high-potential firms rather than simply widen SME participation. Its Recommendation 5 calls for a dedicated frontier-technology procurement framework, an official acknowledgement that today's design may serve the wrong target.

Highland Europe

Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.